Rialto Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.02K Buy
141
+42
+42% +$2.28K ﹤0.01% 680
2026
Q1
$6.21K Buy
99
+75
+313% +$6K ﹤0.01% 539
2025
Q4
$2.29K Buy
24
+3
+14% +$294 ﹤0.01% 701
2025
Q3
$2.05K Sell
21
-3
-13% -$311 ﹤0.01% 665
2025
Q2
$2.58K Sell
24
-2
-8% -$202 ﹤0.01% 565
2025
Q1
$2.62K Buy
+26
New +$2.62K ﹤0.01% 497

Other funds holding BSX

Rialto Wealth Management's BSX Position: Q2 2026 in Review

Rialto Wealth Management increased its Boston Scientific (BSX) stake by 42% in Q2 2026, buying an estimated $2.28K and bringing the position to 141 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Rialto Wealth Management first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.21K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Rialto Wealth Management held 141 shares of Boston Scientific worth $6.02K as of Q2 2026.
  • Rialto Wealth Management bought 42 Boston Scientific shares in Q2 2026, an estimated $2.28K.
  • Boston Scientific made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #680 holding.
  • Rialto Wealth Management first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Rialto Wealth Management's Boston Scientific position peaked at $6.21K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.